# US 2010/0305311 A1 · Nanoparticle for separating peptide, method for preparing the same, and method for separating peptide using the same,

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0305311 A1
- Document ID: US20100305311A1
- Status: Published application
- Kind: A1
- Application number: 12/745,203
- Filed: 2008-11-28
- Published: 2010-12-02
- Earliest claimed: 2007-11-30
- Assignees: Korea University Industrial & Academic Collaboration Foundation
- Inventors: Sang-Won Lee; Kwang-Yeol Lee; Je-Sun Lee; Ji-Young Huh; Min-Sik Kim; Yeon-Ji Lee
- Web page: https://patentgrep.com/patent/US20100305311A1

## CPC

- G01N 33/587: {Nanoparticles}
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- G01N 33/54333: {Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction}
- Y10T 428/2982: Particulate matter [e.g., sphere, flake, etc.]
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

Disclosed are nanoparticles for use in the isolation of peptides, a method for producing the nanoparticles, and a method for the isolation of peptides using the nanoparticles. The nanoparticles comprise magnetic nanoparticles and thiol-specific functional groups as first functional groups bound to the surfaces of the magnetic nanoparticles to selectively capture cysteine-containing peptides. The nanoparticles allow highly selective isolation of target peptides in a simple and rapid manner. Therefore, the nanoparticles can be applied to research on the treatment of diseases such as cancers.

## Claims

### Claim 1

Nanoparticles comprising magnetic nanoparticles and thiol-specific functional groups as first functional groups bound to the surfaces of the magnetic nanoparticles to selectively capture cysteine-containing peptides.

### Claim 2 (depends on 1)

The nanoparticles of claim 1, wherein the first functional group contains a 2-pyridyldisulfide group.

### Claim 3 (depends on 1)

The nanoparticles of claim 1, wherein the magnetic nanoparticles are coated with silica and the first functional groups are bound to the silica layers.

### Claim 4 (depends on 1)

The nanoparticles of claim 1, further comprising second functional groups bound to the surfaces of the magnetic nanoparticles to prevent aggregation of the adjacent nanoparticles.

### Claim 5 (depends on 4)

The nanoparticles of claim 4, wherein the second functional group contains a phosphate group.

### Claim 6 (depends on 1)

The nanoparticles of claim 1, wherein the magnetic nanoparticles are selected from iron oxide, cobalt, nickel, and iron oxide doped with at least one material from manganese and zinc.

### Claim 7 (depends on 1)

The nanoparticles of claim 1, wherein the magnetic nanoparticles have a diameter of 25 to 35 nm.

### Claim 8

A method for producing nanoparticles for use in the isolation of peptides, the method comprising
coating the surfaces of magnetic particles with silica, and
binding thiol-specific functional groups as first functional groups to the silica layers to selectively capture cysteine-containing peptides.

### Claim 9 (depends on 8)

The method of claim 8, wherein the coating step includes dispersing the magnetic particles and a dispersant in a solvent, adding ammonia (NH3) and tetraethylorthosilicate (TEOS) to the dispersion of the magnetic particles to form silica layers on the surfaces of the magnetic particles, and separating the silica-coated magnetic particles from the solvent by precipitation.

### Claim 10 (depends on 8)

The method of claim 8, wherein the first functional group contains a 2-pyridyldisulfide group.

### Claim 11 (depends on 10)

The method of claim 10, wherein the binding step includes dispersing the coated magnetic nanoparticles in a solvent, adding 3-aminopropyltriethoxysilane to the dispersion of the coated magnetic nanoparticles to bind functional groups containing 3-aminopropyl groups to the silica layers, and adding N-succinimidyl 3-(2-pyridyldithio)propionate to the dispersion of the nanoparticles functionalized with the 3-aminopropyl groups to bond 2-pyridyldisulfide groups to the 3-aminopropyl groups.

### Claim 12 (depends on 8)

The method of claim 8, further comprising binding second functional groups to the silica layers to prevent aggregation of the adjacent nanoparticles.

### Claim 13 (depends on 12)

The method of claim 12, wherein the second functional group contains a phosphate group.

### Claim 14 (depends on 13)

The method of claim 13, wherein the binding step includes dispersing the nanoparticles functionalized with the first functional groups in a solvent and adding 3-(trihydroxysilyl)propylmethylphosphonate to the dispersion.

### Claim 15

A method for the isolation of peptides using magnetic nanoparticles, the method comprising
mixing a peptide mixture containing target peptides with nanoparticles having first functional groups selectively capturing the target peptides,
bonding the first functional groups of the nanoparticles to the target peptides, and
separating the captured target peptides from the peptide mixture.

### Claim 16 (depends on 15)

The method of claim 15, wherein the functional groups of the nanoparticles are covalently bonded to the target peptides.

### Claim 17 (depends on 15)

The method of claim 15, wherein the separation step is carried out by using a magnetic material to move the nanoparticles.

### Claim 18 (depends on 15)

The method of claim 15, further comprising isolating the target peptides from the nanoparticles after the separation step.

### Claim 19 (depends on 15)

The method of claim 15, wherein the first functional group is a thiol-specific functional group and the target peptide is a cysteinyl peptide.

### Claim 20 (depends on 19)

The method of claim 19, wherein the thiol-specific functional group contains a 2-pyridyldisulfide group.

### Claim 21 (depends on 15)

The method of claim 15, wherein the nanoparticles further include second functional groups to prevent aggregation of the adjacent nanoparticles.

### Claim 22 (depends on 21)

The method of claim 21, wherein the second functional group contains a phosphate group.

### Claim 23 (depends on 15)

The method of claim 15, wherein the nanoparticles include magnetic nanoparticles selected from iron oxide, cobalt, nickel, and iron oxide doped with at least one material from manganese and zinc.

### Claim 24 (depends on 15)

The method of claim 15, wherein the surfaces of the magnetic nanoparticles are coated with silica.

### Claim 25 (depends on 15)

The method of claim 15, wherein the peptide mixture is a sample of proteins or serum.

### Claim 26 (depends on 25)

The method of claim 25, wherein the target peptides captured by the nanoparticles are peptides or proteins containing cysteine reduced by pretreatment or naturally occurring cysteine in a reduced state.

### Claim 27 (depends on 26)

The method of claim 26, further comprising measuring the proportion of the proteins containing naturally occurring cysteine in a reduced state captured by the nanoparticles in all cysteine-containing proteins.
